维普中文期刊产品整合服务
100篇 您的检索式:作者名="Basso U"
    题名 作者 年代 出处 被引量
1A phase Ⅱ, randomized, non-comparative clinical trial of the effect of bevaeizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival ( PFS6 ) in recurrent, treatment-refractory glioblastoma (GBM)显示文摘Brandes AA Tosoni A Basso U 2008J Clin Oncol2008,26,20:1
2A prospective study on glioblastoma in the elderly 显示文摘Brandes AA Vastola F Basso U 2003Cancer2003,97,3:1
3M30 neoepitope expression in epithelial cancer:quantification of apoptosis in circulating tumor cells by Cell Search analysis显示文摘Rossi E Basso U Celadin R 2010Clin Cancer Res2010,16,21:1
4Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma显示文摘Basso U Brandes AA 2002Euro Cancer2002,38,:1
5Targeted approaches to triple-negative breast cancer:current practice and future direc- tions显示文摘Brunello A Borgato L Basso U 2013Curr Med Chem2013,20,5:1
6Estrogen therapy and risk of breast cancer in postmenopausal woman:a case- control study and results of a multivariate analysis 显示文摘Lumachi F Frigo AC Basso U 2010MenoPause2010,17,3:1
7A prospective study on glioblastoma in the elderly显示文摘Brandes AA Vastola F Basso U 2003Cancer2003,97,3:1
8Parathyroid cancer: etiology, clinical presentation and treatment显示文摘Lumachi F Basso SM Basso U 2006Anticancer Res2006,26,6:1
9First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase Ⅱ study of the Gruppo Italiano Cooperativo di Neuro- Oncologia显示文摘Brandes AA Basso U Reni M 2004J Clin Oncol2004,22,9:1
10Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma显示文摘BASSO U BRANDES A A 2002Eur J Cancer2002,38,10:1
11First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease : clinical outcome and patterns of radiological response 显示文摘Roma A Maruzzo M Basso U 2015Fam Cancer2015,14,2:1
12Malignant hypercalcemia显示文摘BASSO U MARUZZO1 M ROMAL A 0,,23:1
13First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo haliano Cooperativo di Neuro-Oncologia显示文摘Brandes AA Basso U Reni M 2004J Clin Oncol2004,22,:1
14Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase lI study显示文摘BRANDES A A BASSO U VASTOLA F 2003Ann Oncol2003,14,:1
15Biocatalysis in non-conventional media:ionic liquids, supereritical fluids and the gas phase 显示文摘Cantone S Hanefeld U Basso A 2007Green Chem2007,9,:1
16A prospective study on glioblastoma in the elderly显示文摘Brandes AA Vastola F Basso U 2003Cancer2003,97,3:1
17A multidrug combination designed for reversing resistance to BCNU in glioblastoma 显示文摘Brandes AA Turazzi S Basso U 2002Neurology2002,58,12:1
18Diagnostic advances and new trends for the treatment of primary cent ral nervous system lymphoma 显示文摘Basso U Brandes AA 2002Eur J Cancer2002,,38:1
19First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme:a phase Ⅱ study of the Gruppo Italiano Cooperativo di Neuro-Oncologia显示文摘BRANDES A A BASSO U RENI M 2004J Clin Oncol2004,22,9:1
20-- Biocatalysis in non-conventional media ionic liquids, supercritical fluids and the gas phase 显示文摘Cantone S Hanefeld U Basso A 2007Green Chem2007,,9:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费